Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,946,388
-$12,369,968 QoQ
Shares Held
1,828,586
-42.1% QoQ
Ownership
0.269%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Derivatives in GRFS
reported options exposure · as of Mar 31, 2024CallValue
$196,392
CallShares
29,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. GRFS ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in GRFS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,946,388 | 1,828,586 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $25,316,356 | 3,156,653 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $23,986,152 | 2,565,364 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $27,933,506 | 2,804,569 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $19,967,280 | 2,208,770 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,157,431 | 1,850,553 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $13,901,587 | 1,868,493 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,373,048 | 942,911 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,695,962 | 1,061,167 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $196,392 | 29,400 | Call | Defined | 2024-05-13 | |
| 2024-03-31 | $3,865,513 | 578,670 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $795,916 | 68,851 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $723,978 | 79,210 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $855,973 | 93,447 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $913,503 | 123,949 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $551,632 | 64,898 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $540,453 | 87,736 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,679,177 | 225,520 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,983,029 | 169,780 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,560,633 | 138,970 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,168,353 | 216,862 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,902,620 | 167,298 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $71,689,300 | 4,146,287 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $109,798,231 | 5,954,351 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $30,613,536 | 1,764,469 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,509,604 | 137,588 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $856,895 | 42,547 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||